A 2025 Meta-Analysis in non–small-Cell Lung Cancer (NSCLC) Indicates Glucocorticoid Administration Is Significantly Associated With Worse Progression-Free Survival (PFS) and Overall Survival (OS) for Patients on ICIs. WJAMS 2025, 2 (11), 1-3. https://doi.org/10.65336/WJAMS.2025.21101.